The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
nSEPIA aims to bring structure to an area long dominated by subjectivity
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Subscribe To Our Newsletter & Stay Updated
